Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR5 | P51681 | 15/20 | 0.37 |
| ▸ | EEF2K | O00418 | 1/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22189075 | 0.95 | EEF2K (0.35) | CCR5EEF2KGNAI3GNAO1GNAI1 | |
| Iodide SCHEMBL11780602 | 0.90 | EEF2K (0.38) | CCR5EEF2KGNAI3GNAO1GNAI1 | |
| SCHEMBL2170722 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL9193826 | 0.84 | KMT2A (0.36) | CCR5TBXAS1 | |
| Pentadecane SCHEMBL9194910 | 0.84 | KMT2A (0.36) | CCR5TBXAS1 | |
| Hydrochloric Acid SCHEMBL2007982 | 0.82 | CCR5 (0.39) | CCR5EEF2KGNAI3GNAO1GNAI1 | |
| SCHEMBL9193515 | 0.82 | HTT (0.36) | CCR5TBXAS1 | |
| Pentadecane SCHEMBL9194866 | 0.82 | HTT (0.36) | CCR5TBXAS1 | |
| SCHEMBL6520656 | 0.82 | — | — | |
| Pentadecane SCHEMBL9654422 | 0.81 | HSP90AA1 (0.36) | TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1824804-A4 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | NALCO CO (US) | 2009-03-04 | — | — | EP | claimed |
| US-20080064611-A1 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | ECOLAB USA INC. | 2008-03-13 | — | — | US | claimed |
| EP-1824804-A2 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | Nalco Company (US) | 2007-08-29 | — | — | EP | claimed |
| WO-2006052455-A2 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | NALCO COMPANY (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060094913-A1 | Ion pair amphiphiles as hydrate inhibitors | NALCO ENERGY SERVICES | 2006-05-04 | — | — | US | claimed |
| EP-1824804-A4 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | NALCO CO (US) | 2009-03-04 | — | — | EP | disclosed |
| US-20080064611-A1 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | ECOLAB USA INC. | 2008-03-13 | — | — | US | disclosed |
| EP-1824804-A2 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | Nalco Company (US) | 2007-08-29 | — | — | EP | disclosed |
| WO-2006052455-A2 | ION PAIR AMPHIPHILES AS HYDRATE INHIBITORS | NALCO COMPANY (US) | 2006-05-18 | — | — | WO | disclosed |
| US-20060094913-A1 | Ion pair amphiphiles as hydrate inhibitors | NALCO ENERGY SERVICES | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094913-A1 | Ion pair amphiphiles as hydrate inhibitors | AQP1, AQP4, AQP3 | CCR5 4706/4885EEF2K 2847/4885GNAI3 861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.